Ivermectin Cancer Study Begins

Observing the Effects of Ivermectin on Turbo Cancers

Dr. Harvey Risch, one of the world’s most esteemed epidemiologists, has stated that Turbo Cancers represent a new and different type of condition. For example, Dr. Risch explains that the sudden development of colon cancer in a young person with no known family history means that something completely novel is now happening to cause this.

Dr. Harvey Risch is a Professor Emeritus of Epidemiology at Yale University.

“Cancer as a disease takes a long time to manifest itself from when it starts, from the first cells that go haywire until they grow to be large enough to be diagnosed or to be symptomatic, can take anywhere from two or three years for the blood cancers, like leukemias and lymphomas, to five years for lung cancer, to 20 years for bladder cancer, or 30, 35 years for colon cancer, and so on.”

We know that colon cancers usually take decades to develop and begin with an adenomatous polyp. This polyp slowly undergoes malignant transformation under carcinogenic conditions - which might involve insulin resistance, diabetes, damage to mitochondria, an altered gut microbiome, lack of exercise, and an inflammatory diet. The cancer expands to gradually invade the mucosal wall, and then the surrounding tissues and lymph nodes. By the time this all plays out, the person is usually in their 50s or 60s.

In the rare cases of genetic colon cancer, like Familial Adenomatous Polyposis (FAP) or Hereditary Non-polyposis Colorectal Cancer (HNPCC), it can occur in young people. However, we are now seeing full-blown non-genetic colon cancers develop suddenly in 20, 30 and 40-year-olds in large numbers which is unprecedented.

According to Dr. Risch, if a 25-year-old develops colon cancer without a family history of the disease, then something else must be at play.

“That’s basically impossible along the known paradigm for how colon cancer works,” he notes. “Because these cancers have been occurring in people who are too young to get them, basically, compared to the normal way it works, they’ve been designated as Turbo Cancers,” Risch explained.

Other esteemed scientists, statisticians, and researchers have also sounded the alarm as we notice massive increases in non-COVID death around the globe in the younger age groups of otherwise healthy and gainfully employed individuals. Among these researchers are Dr. Angus Dalgleish, Dr. William Makis, Dr. Peter McCullough, Dr. Ryan Cole, and Edward Dowd.

What is killing these young people?

Increasing Turbo Cancers are certainly part of the equation, and Dr. Paul Marik has recently completed his review of the role of repurposed drugs and metabolic therapy in the prevention and treatment of cancer.

Dr. Marik has personally taken the lead in the Repurposed Drug Revolution, and now is launching a study on the use of Ivermectin and other repurposed drugs for the treatment of Turbo Cancers which will in many cases include colon cancer.

Along with Dr. Kathleen Ruddy, a Sloan-Kettering-trained physician, Dr. Marik is launching an observational study which will involve various repurposed drugs and metabolic treatments for patients suffering from advanced cancers.

With Ivermectin, Dr. Ruddy has observed some amazing results, and this study represents a scientific way - beyond anecdote - to measure Ivermectin’s effectiveness against a variety of malignancies. The observational study will look at the effects of dose, timeline of administration, and response to treatment.

In a recent FLCCC Webinar Drs. Ruddy and Marik explained that patients will make the determination of the specific repurposed drugs and metabolic interventions they want.

These may include Ivermectin [high or low dose], Mebendazole, Metformin, Vitamin D, Fish Oil, Curcumin, Green Tea, and Melatonin. They may also include sunlight, overnight fasting, a ketogenic diet, and daily resistance or aerobic exercise.

The patients will determine if they wish to combine these with the traditional treatments of chemotherapy, radiation, or surgery which have come under heavy recent criticism as being toxic, damaging, and often ineffective.

Dr. Marik explains that it is time for patients to decide which treatments and risks they wish to take, rather than being told what they will do by paternalistic Oncologists.

Marik and Ruddy will both be speaking at a landmark medical conference in Phoenix, Arizona - ‘Healthcare Revolution: Restoring the Doctor-Patient Relationship’ - kicking off today.